Clinical Trial Update: Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

View source ↗

Summary

A retrospective multicenter cohort study comparing the efficacy and safety of telitacicept versus belimumab in lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Belimumab (belimumab)
• Telitacicept

Snippet

Sponsor: Yipeng Liu | Conditions: Lupus Nephritis, Belimumab | Status: COMPLETED